Silence Therapeutics SLN
NASDAQ SLN
$14.55 -0.24 (-1.62%)
As of: Sep 4, 2026 · 2:42 PM EDT

Silence Therapeutics (SLN) Cash & Equivalents (QoQ) (2025 - 2026)

Analysis

Silence Therapeutics (SLN) Cash & Equivalents (QoQ) (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.74 Bn 130.89 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.52 Bn 77.52 Bn 3.93 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn
4 Moderna 58.04 Bn 52.91 Bn 52.00 Mn
5 Revolution Medicines 44.06 Bn 44.06 Bn -
6 BeOne Medicines 39.98 Bn 34.88 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.46 Bn 32.15 Bn 992.69 Mn
8 Royalty Pharma 28.41 Bn 27.57 Bn -
9 Insmed 27.44 Bn 26.28 Bn 358.27 Mn
10 Silence Therapeutics 688.71 Mn 616.61 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.85%
Mar 31, 2026 521.62%
Dec 31, 2025 -88.97%
Sep 30, 2025 -10.51%
Jun 30, 2025 -16.34%
Mar 31, 2025 12.50%